Sarc
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2003-01-01
- Employees
- -
- Market Cap
- -
Neoadjuvant Imatinib in Dermatofibrosarcoma Protuberans
- First Posted Date
- 2005-10-21
- Last Posted Date
- 2012-03-29
- Target Recruit Count
- 18
- Registration Number
- NCT00243191
- Locations
- 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
🇺🇸Pennsylvania Onc/Hem Assoc., Philadelphia, Pennsylvania, United States
🇺🇸University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States
Gemcitabine and Docetaxel in Treating Patients With Recurrent Osteosarcoma (Closed to Accrual as of 12/21/06) or Ewing's Sarcoma or Unresectable or Locally Recurrent Chondrosarcoma
Phase 2
Completed
- Conditions
- Sarcoma
- First Posted Date
- 2003-12-11
- Last Posted Date
- 2012-03-12
- Target Recruit Count
- 54
- Registration Number
- NCT00073983
© Copyright 2025. All Rights Reserved by MedPath